Search by Drug Name or NDC
NDC 70710-1167-01 Atenolol and Chlorthalidone 50; 25 mg/1; mg/1 Details
Atenolol and Chlorthalidone 50; 25 mg/1; mg/1
Atenolol and Chlorthalidone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ATENOLOL; CHLORTHALIDONE.
MedlinePlus Drug Summary
Atenolol is used alone or in combination with other medications to treat high blood pressure. It also is used to prevent angina (chest pain) and improve survival after a heart attack. Atenolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 70710-1167-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Atenolol
Chlorthalidone, a 'water pill,' is used to treat high blood pressure and fluid retention caused by various conditions, including heart disease. It causes the kidneys to get rid of unneeded water and salt from the body into the urine. This medicine is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 70710-1167-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Chlorthalidone
Product Information
| NDC | 70710-1167 |
|---|---|
| Product ID | 70710-1167_f3604313-4dc9-49c1-911c-6178d9939f84 |
| Associated GPIs | 36992002100310 |
| GCN Sequence Number | 000420 |
| GCN Sequence Number Description | atenolol/chlorthalidone TABLET 50 MG-25MG ORAL |
| HIC3 | J7H |
| HIC3 Description | BETA-BLOCKERS AND THIAZIDE,THIAZIDE-LIKE DIURETICS |
| GCN | 66990 |
| HICL Sequence Number | 000147 |
| HICL Sequence Number Description | ATENOLOL/CHLORTHALIDONE |
| Brand/Generic | Generic |
| Proprietary Name | Atenolol and Chlorthalidone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Atenolol and Chlorthalidone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50; 25 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ATENOLOL; CHLORTHALIDONE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide-like Diuretic [EPC], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210028 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 70710-1167-01 (70710116701)
| NDC Package Code | 70710-1167-1 |
|---|---|
| Billing NDC | 70710116701 |
| Package | 100 TABLET in 1 BOTTLE (70710-1167-1) |
| Marketing Start Date | 2019-03-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.31284 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | ATENOLOL-CHLORTHALIDONE 50-25 |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |